Form 4: Masimo Corporation Acquired by Danaher for $180 Per Share

Director Wendy E. Lane reports the disposal of Masimo Corporation common stock and RSUs following the company's acquisition by Danaher Corporation.

Summary

• Masimo Corporation completed a merger with a subsidiary of Danaher Corporation on June 10, 2026.
• Director Wendy E. Lane disposed of 2,608 shares of common stock at a price of $180.00 per share.
• 1,119 restricted stock units (RSUs) held by the director were canceled and converted into the right to receive $180.00 per share in cash.
• Masimo Corporation is now a wholly owned subsidiary of Danaher Corporation.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the completion of a previously announced merger.

Positives

• Shareholders received a cash consideration of $180.00 per share upon the completion of the merger.

Negatives

• The company is no longer an independent publicly traded entity.

Risks

• No ongoing risks as the company has been acquired and delisted.

Future Outlook

The company has been acquired by Danaher Corporation and is now a wholly owned subsidiary; no further independent guidance is provided.

Industry Context

StockSavvy.ai notes that this acquisition represents a significant consolidation in the medical technology sector, with Danaher expanding its portfolio through the absorption of Masimo's monitoring technologies.

Comparison to Industry Standards

• The $180 per share valuation reflects the final exit price for public shareholders following the merger agreement.

Legal Proceedings

• The merger was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Stakeholder Impact

• Shareholders have had their equity converted to cash at the agreed merger price.
• The company is now a subsidiary of Danaher Corporation.

Next Steps

• Finalization of all equity conversions and delisting procedures.

Key Dates

Keywords

Masimo, Danaher, Merger, Acquisition, Form 4, Insider Transaction